Abstract
The CHANGE (Cessation of Heroin: A Neighborhood Grounded Exploration) Study aimed to understand factors associated with the initiation and maintenance of sustained heroin cessation from the perspective of users themselves and specifically set out to document the correlates of natural recovery. The CHANGE Study was a case-control study conducted in New York City from 2009 to 2011. Cases were former heroin users, abstinent for 1–5 years in the past 5 years. Controls used heroin at least weekly during the past 5 years and were (1) continuous heroin users without a quit attempt of ≥2 weeks’ duration or (2) relapsed heroin users who were currently using and had a quit attempt of ≥2 weeks’ duration during the past 5 years. Recruitment and data collection methods are described along with limitations and a brief description of the study sample. In contrast to many studies of drug use and cessation, the CHANGE Study was designed to model success (i.e., initiation and maintenance of heroin cessation) and not failure.
Similar content being viewed by others
References
Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. http://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabsPDFWHTML2013/Web/HTML/NSDUH-DetTabsTOC2013.htm. Accessed 9 Jan 2015.
Darke S. The life of the heroin user: typical beginnings, trajectories and outcomes. Cambridge (UK): Cambridge University Press; 2011.
Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013; 382(9904): 1564–1574.
Degenhardt L, Charlson F, Mathers B, et al. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction. 2014; 109(8): 1320–1333.
Mark TL, Woody GE, Juday T, Kleber HD. The economic costs of heroin addiction in the United States. Drug Alcohol Depend. 2001; 61(2): 195–206.
Inocencio TJ, Carroll NV, Read EJ, Holdford DA. The economic burden of opioid-related poisoning in the United States. Pain Med. 2013; 14(10): 1534–1547.
Hser YI, Anglin D, Powers K. A 24-year follow-up of California narcotics addicts. Arch Gen Psychiatry. 1993; 50(7): 577–584.
Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001; 58(5): 503–508.
Vaillant GE. A 20-year follow-up of New York narcotic addicts. Arch Gen Psychiatry. 1973; 29(2): 237–241.
Simpson DD, Joe GW, Lehman WEK, Sells SB. Addiction careers—etiology, treatment, and 12-year follow-up outcomes. J Drug Issues. 1986; 16(1): 107–121. Win.
Biernacki P. Pathways from heroin addiction: recovery without treatment. Philadelphia: Temple University Press; 1986.
Nurco DN, Cisin IH, Balter MB. Addict careers. I. A new typology. Int J Addict. 1981; 16(8): 1305–1325.
Waldorf D, Biernacki P. Natural recovery from heroin-addiction—review of the incidence literature. J Drug Issues. 1979; 9(2): 281–289.
Waldorf D, Biernacki P. The natural recovery from opiate addiction—some preliminary findings. J Drug Issues. 1981; 11(1): 61–74.
Stall R, Biernacki P. Spontaneous remission from the problematic use of substances—an inductive model derived from a comparative-analysis of the alcohol, opiate, tobacco, and food obesity literatures. Int J Addict. 1986; 21(1): 1–23.
Hubbard RL, Craddock SG, Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat. 2003; 25(3): 125–134.
Hser YI. Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up study. J Addict Dis. 2007; 26(1): 51–60.
Darke S, Ross J, Teesson M, et al. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). J Subst Abuse Treat. 2005; 28(3): 255–263.
Darke S, Ross J, Mills KL, Williamson A, Havard A, Teesson M. Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS). Addict Behav. 2007; 32(9): 1897–1906.
Darke S, Mills KL, Ross J, Williamson A, Havard A, Teesson M. The ageing heroin user: career length, clinical profile and outcomes across 36 months. Drug Alcohol Rev. 2009; 28(3): 243–249.
Klingemann HK, Sobell LC. Introduction: natural recovery research across substance use. Subst Use Misuse. 2001; 36(11): 1409–1416.
Preble E, Casey JJ. Taking care of business—heroin users life on street. Int J Addict. 1969; 4(1): 1–24.
Granfield R, Cloud W. Social context and “natural recovery”: the role of social capital in the resolution of drug-associated problems. Subst Use Misuse. 2001; 36(11): 1543–1570.
Bischof G, Rumpf HJ, Meyer C, Hapke U, John U. Stability of subtypes of natural recovery from alcohol dependence after two years. Addiction. 2007; 102(6): 904–908.
Sobell LC, Ellingstad TP, Sobell MB. Natural recovery from alcohol and drug problems: methodological review of the research with suggestions for future directions. Addiction. 2000; 95(5): 749–764.
Burman S. The challenge of sobriety: natural recovery without treatment and self-help groups. J Subst Abuse. 1997; 9: 41–61.
Chiauzzi EJ, Liljegren S. Taboo topics in addiction treatment. An empirical review of clinical folklore. J Subst Abuse Treat. 1993; 10(3): 303–316.
Graeven DB, Graeven KA. Treated and untreated addicts—factors associated with participation in treatment and cessation of heroin use. J Drug Issues. 1983; 13(2): 207–218.
Klingemann HK. The motivation for change from problem alcohol and heroin use. Br J Addict. 1991; 86(6): 727–744.
Price RK, Risk NK, Spitznagel EL. Remission from drug abuse over a 25-year period: patterns of remission and treatment use. Am J Public Health. 2001; 91(7): 1107–1113.
Biernacki P. Recovery from opiate addiction without treatment: a summary. NIDA Res Monogr. 1990; 98: 113–119.
Weiss L, Ompad D, Galea S, Vlahov D. Defining neighborhood boundaries for urban health research. Am J Prev Med. 2007; 32(6 Suppl): S154–S159.
O’Brien CP. Drug addiction and drug abuse. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006.
Weiss L, Gass J, Egan JE, Ompad DC, Trezza C, Vlahov D. Understanding prolonged cessation from heroin use: findings from a community-based sample. J Psychoactive Drugs. 2014; 46(2): 123–132.
Fox AD, Anderson MR, Bartlett G, Valverde J, Starrels JL, Cunningham CO. Health outcomes and retention in care following release from prison for patients of an urban post-incarceration transitions clinic. J Health Care Poor Underserved. 2014; 25(3): 1139–1152.
Fox AD, Maradiaga J, Weiss L, Sanchez J, Starrels JL, Cunningham CO. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder. Addict Sci Clin Pract. 2015; 10(1): 2.
Hser YI, Evans E, Grella C, Ling W, Anglin D. Long-term course of opioid addiction. Harv Rev Psychiatry. 2015; 23(2): 76–89.
Nurco DN, Cisin IH, Balter MB. Addict careers. III. Trends across time. Int J Addict. 1981; 16(8): 1357–1372.
Nurco DN, Cisin IH, Balter MB. Addict careers. II. The first ten years. Int J Addict. 1981; 16(8): 1327–1356.
Winick C. Maturing out of narcotic addiction. Bull Narc. 1962; 14(1): 1–7.
Smith WG, Ellinwood EH, Vaillant GE. Narcotic addicts in the mid-1960’s. Public Health Rep. 1966; 81(5): 403–412.
Vaillant GE. Twelve-year follow-up of New York narcotic addicts. II. The natural history of a chronic disease. N Engl J Med. 1966; 275(23): 1282–1288.
Vaillant GE. A 12-year follow-up of New York narcotic addicts. 3. Some social and psychiatric characteristics. Arch Gen Psychiatry. 1966; 15(6): 599–609.
Vaillant GE. A twelve-year follow-up of New York narcotic addicts: IV. Some characteristics and determinants of abstinence. Am J Psychiatry. 1966; 123(5): 573–585.
Vaillant GE. A twelve-year follow-up of New York narcotic addicts. I. The relation of treatment to outcome. Am J Psychiatry. 1966; 122(7): 727–737.
Vaillant GE. The natural history of narcotic drug addiction. Semin Psychiatry. 1970; 2(4): 486–498.
Waldorf D. Natural recovery from opiate addiction—some social-psychological processes of untreated recovery. J Drug Issues. 1983; 13(2): 237–280.
Tsuang MT, Lyons MJ, Meyer JM, et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry. 1998; 55(11): 967–972.
Blazer DG, Wu LT. The epidemiology of substance use and disorders among middle aged and elderly community adults: national survey on drug use and health. Am J Geriatr Psychiatry. 2009; 17(3): 237–245.
Palamar JJ, Ompad DC. Demographic and socioeconomic correlates of powder cocaine and crack use among high school seniors in the United States. Am J Drug Alcohol Abuse. 2014; 40(1): 37–43.
Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–98. Addiction. 2003; 98(6): 739–747.
Darke S, Marel C, Mills KL, et al. Patterns and correlates of non-fatal heroin overdose at 11-year follow-up: findings from the Australian Treatment Outcome Study. Drug Alcohol Depend. 2014; 144: 148–152.
U.S. Census Bureau. Poverty thresholds 2009; 2010. https://www.census.gov/hhes/www/poverty/data/threshld/thresh09.html. Accessed 11 Jan 2015.
Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014; 71(7): 821–826.
Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS): Table 2.2. Admissions aged 12 and older, by race/ethnicity according to primary substance of abuse: 2012; 2013. http://www.samhsa.gov/data/sites/default/files/TEDS2012N_Web/TEDS2012NTbl2.2.htm. Accessed 11 Jan 2015.
Acknowledgments
This study was funded by a grant from the National Institute on Drug Abuse (DA022123). DCO was also supported by the NIDA-funded Center for Drug Use and HIV Research (CDUHR—P30 DA011041). JJP is also supported by a grant from NIDA (K01 DA038800).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ompad, D.C., Benjamin, E.O., Weiss, L. et al. The CHANGE Study: Methods and Sample Description for a Cross-Sectional Study of Heroin Cessation in New York City. J Urban Health 92, 955–965 (2015). https://doi.org/10.1007/s11524-015-9973-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11524-015-9973-0